Spondyloarthropathies
Conference Coverage
COVID-19 vaccine hesitancy still weighs heavy for some rheumatic disease patients
ACR COVID-19 vaccine task force chair Dr. Jeffrey Curtis goes over the latest evidence about COVID-19 vaccination in patients with rheumatic and...
From the Journals
Researchers follow development of axial SpA in first-degree relatives of patients
Progression to axial SpA was more likely in first-degree relatives of HLA-B27–positive patients who also were HLA-B27 positive, compared to those...
From the Journals
Malignancy risk: Secukinumab shows long-term safety for psoriasis, PsA, ankylosing spondylitis
Malignancy rates were low in a large study of secukinumab in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis.
Conference Coverage
TNF inhibitors have delayed effect on spondyloarthritis radiographic progression
It could take 2-4 years before plain radiographs show any sign of a benefit on the spine or sacroiliac joints.
From the Journals
Lower SARS-CoV-2 vaccine responses seen in patients with immune-mediated inflammatory diseases
Patients who take methotrexate or rituximab seem to be especially vulnerable.
Conference Coverage
Multiple studies highlight pandemic’s impact on patients with rheumatic disease
From the Europe-based REUMAVID study to the United Kingdom’s CONTAIN study, some common themes are emerging, with lessons to be learned for future...
Feature
Boosting the presence of darker skin in rheumatology education
Doctors are beginning to address educational gaps in rheumatologists’ exposure to rheumatic and musculoskeletal diseases in people with darker...
From the Journals
Most patients with chronic inflammatory diseases have sufficient response to COVID-19 vaccination
A preprint publication of a study of 133 people with chronic inflammatory disease and 53 controls shows that those with CID mount immune responses...
From the Journals
Rheumatology clinics find success with smoking cessation referral program
Clinics that adopted a protocolized, EHR-based approach to checking for readiness to quit saw a 26-fold increase in quit-line referrals.
From the Journals
Researchers stress importance of second COVID-19 vaccine dose for infliximab users
Significantly lower antibody concentrations seen after a first dose of the Pfizer or AstraZeneca vaccine in users of infliximab vs. vedolizumab...
From the Journals
COVID-19 vaccination in RMD patients: Safety data “reassuring”
Two studies show mainly mild reactions and favorable antibody responses in patients with rheumatic and musculoskeletal diseases after vaccination...